Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Net Change in Cash

The Net Change in Cash of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 18, 2026 is -517.56 M CNY. In the previous year, Net Change in Cash was -56.28 M CNY — a change of 819.63% (lower).

Net Change in Cash

-517.56 MCNY

YoY

819.63%

Last updated:

Net Change in Cash of Vcanbio Cell & Gene Engineering Corp is 2025 -517.56 M CNY. Net Change in Cash of Vcanbio Cell & Gene Engineering Corp was 2024 -56.28 M CNY. It decreases by 819.63% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
109.31 M CNY
Jan 1, 2019
46.45 M CNY
Jan 1, 2020
428.63 M CNY
Jan 1, 2021
129.75 M CNY
Jan 1, 2022
191.10 M CNY
Jan 1, 2023
200.02 M CNY
Jan 1, 2024
-56.28 M CNY
Jan 1, 2025
-517.56 M CNY
The Vcanbio Cell & Gene Engineering Corp Net Change in Cash history
YEARNet Change in CashYoY
-517.56 MCNY+819.63%
-56.28 MCNY-128.14%
200.02 MCNY+4.67%
191.10 MCNY+47.28%
129.75 MCNY-69.73%
428.63 MCNY+822.77%
46.45 MCNY-57.51%
109.31 MCNY+648.12%
14.61 MCNY-104.96%
-294.85 MCNY-235.06%
218.31 MCNY-143.95%
-496.71 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp Ltd is a biotechnology company based in Tianjin, China, operating within the healthcare sector. The company has been publicly traded since its IPO on May 4, 1993, and is listed under the ticker 600645.SS with ISIN CNE000000545. It employs 2,332 full-time staff and focuses on the development of life sciences technology. Vcanbio engages in cell culture, gene detection, and storage services, as well as the production and sale of cytokines culture solutions, cosmetics, and detection reagents. The company primarily serves domestic markets in China, with its headquarters located in Tianjin. Its website is http://www.vcanbio.com. The firm's business activities include the development and application of biotechnology solutions, though specific details on product names, acquisitions, or additional financial figures are not provided in the available information. Vcanbio operates as a public company with a presence in the Chinese biotechnology industry, emphasizing innovation in cell and gene engineering. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Net Change in Cash of Vcanbio Cell & Gene Engineering Corp is -517.56 M CNY in 2025.

Net Change in Cash of Vcanbio Cell & Gene Engineering Corp changed from -56.28 M CNY to -517.56 M CNY, representing a 819.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Vcanbio Cell & Gene Engineering Corp

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Vcanbio Cell & Gene Engineering Corp